COVID-19 PROPHYLAXIS GONE TERRIBLY WRONG: CASE OF IVERMECTIN TOXICITY

被引:0
作者
Akhlaq, Hira
Zolezi, Sydney
Farhat, Farah
Patel, Purvi
Kozlik, Ann
Abu Homoud, Ahmad
Sen, Shuvendu
Tafa, Medin
机构
关键词
D O I
10.1016/j.chest.2023.07.1572
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:2340A / 2341A
页数:2
相关论文
共 3 条
[1]   The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [J].
Caly, Leon ;
Druce, Julian D. ;
Catton, Mike G. ;
Jans, David A. ;
Wagstaff, Kylie M. .
ANTIVIRAL RESEARCH, 2020, 178
[2]   Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2 [J].
Lehrer, Steven ;
Rheinstein, Peter H. .
IN VIVO, 2020, 34 (05) :3023-3026
[3]   Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities The I-TECH Randomized Clinical Trial [J].
Lim, Steven Chee Loon ;
Hor, Chee Peng ;
Tay, Kim Heng ;
Jelani, Anilawati Mat ;
Tan, Wen Hao ;
Ker, Hong Bee ;
Chow, Ting Soo ;
Zaid, Masliza ;
Cheah, Wee Kooi ;
Lim, Han Hua ;
Khalid, Khairil Erwan ;
Cheng, Joo Thye ;
Unit, Hazfadzila Mohd ;
An, Noralfazita ;
Nasruddin, Azraai Bahari ;
Low, Lee Lee ;
Khoo, Song Weng Ryan ;
Loh, Jia Hui ;
Zaidan, Nor Zaila ;
Ab Wahab, Suhaila ;
Song, Li Herng ;
Koh, Hui Moon ;
King, Teck Long ;
Lai, Nai Ming ;
Chidambaram, Suresh Kumar ;
Peariasamy, Kalaiarasu M. .
JAMA INTERNAL MEDICINE, 2022, 182 (04) :426-435